CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 4 filers reported holding CONMED CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,772,966 | -23.4% | 305,136 | +3.3% | 0.01% | -18.2% |
| Q2 2023 | $40,151,690 | +33.9% | 295,472 | +2.3% | 0.01% | +22.2% |
| Q1 2023 | $29,993,522 | +21.4% | 288,788 | +3.6% | 0.01% | +12.5% |
| Q4 2022 | $24,712,300 | +16.1% | 278,794 | +5.0% | 0.01% | 0.0% |
| Q3 2022 | $21,292,000 | -14.5% | 265,579 | +2.1% | 0.01% | -11.1% |
| Q2 2022 | $24,906,000 | -35.2% | 260,078 | +0.5% | 0.01% | -25.0% |
| Q1 2022 | $38,436,000 | +6.6% | 258,734 | +1.7% | 0.01% | +9.1% |
| Q4 2021 | $36,071,000 | +10.5% | 254,443 | +2.0% | 0.01% | 0.0% |
| Q3 2021 | $32,645,000 | -2.8% | 249,520 | +2.2% | 0.01% | 0.0% |
| Q2 2021 | $33,570,000 | +4.1% | 244,266 | -1.1% | 0.01% | -8.3% |
| Q1 2021 | $32,257,000 | +12.6% | 247,005 | -3.4% | 0.01% | +9.1% |
| Q4 2020 | $28,649,000 | +21.3% | 255,788 | -14.8% | 0.01% | 0.0% |
| Q3 2020 | $23,609,000 | +8.7% | 300,099 | -0.6% | 0.01% | 0.0% |
| Q2 2020 | $21,726,000 | +42.4% | 301,785 | +13.3% | 0.01% | +22.2% |
| Q1 2020 | $15,255,000 | -39.2% | 266,363 | +18.6% | 0.01% | -30.8% |
| Q4 2019 | $25,106,000 | +17.5% | 224,498 | +1.0% | 0.01% | 0.0% |
| Q3 2019 | $21,365,000 | +18.6% | 222,204 | +5.5% | 0.01% | +18.2% |
| Q2 2019 | $18,021,000 | -3.0% | 210,598 | -5.7% | 0.01% | -8.3% |
| Q1 2019 | $18,576,000 | +36.8% | 223,317 | +5.6% | 0.01% | +20.0% |
| Q4 2018 | $13,582,000 | -12.0% | 211,557 | +8.6% | 0.01% | 0.0% |
| Q3 2018 | $15,438,000 | +10.3% | 194,873 | +1.9% | 0.01% | 0.0% |
| Q2 2018 | $13,993,000 | +19.5% | 191,156 | +3.4% | 0.01% | +11.1% |
| Q1 2018 | $11,707,000 | +24.8% | 184,850 | +0.5% | 0.01% | +28.6% |
| Q4 2017 | $9,379,000 | +2.1% | 183,996 | +5.2% | 0.01% | -12.5% |
| Q3 2017 | $9,182,000 | +7.7% | 174,980 | +4.6% | 0.01% | 0.0% |
| Q2 2017 | $8,525,000 | +17.6% | 167,338 | +2.5% | 0.01% | +14.3% |
| Q1 2017 | $7,248,000 | +10.5% | 163,186 | +9.9% | 0.01% | 0.0% |
| Q4 2016 | $6,558,000 | +21.1% | 148,466 | +9.8% | 0.01% | +16.7% |
| Q3 2016 | $5,417,000 | -12.0% | 135,214 | +4.9% | 0.01% | -25.0% |
| Q2 2016 | $6,156,000 | +21.2% | 128,959 | +6.5% | 0.01% | +14.3% |
| Q1 2016 | $5,078,000 | -1.4% | 121,061 | +3.6% | 0.01% | 0.0% |
| Q4 2015 | $5,148,000 | -1.2% | 116,855 | +7.1% | 0.01% | -12.5% |
| Q3 2015 | $5,210,000 | -18.3% | 109,129 | -0.3% | 0.01% | -11.1% |
| Q2 2015 | $6,379,000 | -19.6% | 109,458 | -30.4% | 0.01% | -18.2% |
| Q1 2015 | $7,937,000 | -18.4% | 157,182 | -27.4% | 0.01% | -26.7% |
| Q4 2014 | $9,732,000 | +15.2% | 216,448 | -5.6% | 0.02% | +7.1% |
| Q3 2014 | $8,445,000 | -16.8% | 229,215 | -0.3% | 0.01% | -17.6% |
| Q2 2014 | $10,155,000 | -9.9% | 229,993 | -11.3% | 0.02% | -15.0% |
| Q1 2014 | $11,270,000 | +5.1% | 259,367 | +2.8% | 0.02% | 0.0% |
| Q4 2013 | $10,725,000 | +20.6% | 252,348 | -2.7% | 0.02% | +11.1% |
| Q3 2013 | $8,895,000 | +4.6% | 259,315 | -3.2% | 0.02% | -5.3% |
| Q2 2013 | $8,507,000 | – | 267,843 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |